Status:
UNKNOWN
PRECISion medicinE Across the Disease Continuum to Prevent and Treat Rheumatoid Arthritis
Lead Sponsor:
University of Manchester
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
The study will recruit patients referred to the Rheumatology Out-patient departments. Patients will be recruited to the study or control groups (healthy or disease controls who will be age and sex-mat...
Detailed Description
Main Study Consent to this ethics' main programme will permit collection of routinely collected data and use for research activities. Patients may be recruited at any point along their disease contin...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Subject ≥ 18 years of age
- Is capable of understanding and signing an informed consent form
- Falls into one of the following:
- Pre-RA - Any musculoskeletal symptom (inflammatory and/or non-inflammatory) AND either RF and/orACPA positive.
- UA - Inflammatory joint symptoms (including joint pain, significant early morning stiffness and joint swelling) not fulfilling any classification criteria
- ERA - recent clinical diagnosis of RA EstRA - known diagnosis of RA supported by evidence of established inflammatory arthritis including but not limited to synovitis, erosion, tenosynovitis.
- Exclusion Criteria
- Age less than 18 years
- Lack of capacity to give informed consent
Exclusion
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04482335
Start Date
May 15 2021
End Date
October 1 2025
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester Royal Infirmary
Manchester, Greater Manchester, United Kingdom, M13 9WL